Abstract
Background: OSA is a common disorder with significant neuropsychiatric morbidity. Studies have shown a 20% prevalence of depression in OSA patients. Prevalence of anxiety disorders in OSA has not been well characterized.
Objective: The objective of this study was to examine the prevalence of depression and anxiety disorders in a cohort of patients with OSA, and evaluate the influence of gender and ethnicity.
Methodology: A retrospective study was carried out on consecutive patients referred for polysomnography at our tertiary care county hospital sleep center. Patients were administered the Hospital Anxiety and Depression Scale (HADS) in addition to routine sleep questionnaires. Scores of >10 were considered positive for both anxiety, and for depression respectively. Patients over age 18 years and AHI > 5 on the sleep study were included in the analysis.
Results: 51 patients meeting the inclusion criteria filled out a valid questionnaire. The prevalence of both anxiety, as well as depression, was very high (52.9 % and 39.2% respectively). There was a significantly higher prevalence of anxiety in females as compared to males. (62.5% vs 36.8% respectively; p < 0.05). African-American patients had higher rates of anxiety than Caucasians (66.7% vs 30.7%; p < 0.05). No gender or ethnic variance was seen in prevalence of depression.
Conclusions: Anxiety, as well as depression, are extremely prevalent in patients with OSA, and are significantly underappreciated. Our data suggest that both gender and ethnicity may influence the prevalence of anxiety in OSA.
Keywords: Anxiety, depression, ethnic variances, obstructive sleep apnea.
Current Respiratory Medicine Reviews
Title:Anxiety and Depression in Obstructive Sleep Apnea: Prevalence and Gender/Ethnic Variance
Volume: 9 Issue: 4
Author(s): Salim Surani, Shweta Rao, Saherish Surani, Bharat Guntupalli and Shyam Subramanian
Affiliation:
Keywords: Anxiety, depression, ethnic variances, obstructive sleep apnea.
Abstract: Background: OSA is a common disorder with significant neuropsychiatric morbidity. Studies have shown a 20% prevalence of depression in OSA patients. Prevalence of anxiety disorders in OSA has not been well characterized.
Objective: The objective of this study was to examine the prevalence of depression and anxiety disorders in a cohort of patients with OSA, and evaluate the influence of gender and ethnicity.
Methodology: A retrospective study was carried out on consecutive patients referred for polysomnography at our tertiary care county hospital sleep center. Patients were administered the Hospital Anxiety and Depression Scale (HADS) in addition to routine sleep questionnaires. Scores of >10 were considered positive for both anxiety, and for depression respectively. Patients over age 18 years and AHI > 5 on the sleep study were included in the analysis.
Results: 51 patients meeting the inclusion criteria filled out a valid questionnaire. The prevalence of both anxiety, as well as depression, was very high (52.9 % and 39.2% respectively). There was a significantly higher prevalence of anxiety in females as compared to males. (62.5% vs 36.8% respectively; p < 0.05). African-American patients had higher rates of anxiety than Caucasians (66.7% vs 30.7%; p < 0.05). No gender or ethnic variance was seen in prevalence of depression.
Conclusions: Anxiety, as well as depression, are extremely prevalent in patients with OSA, and are significantly underappreciated. Our data suggest that both gender and ethnicity may influence the prevalence of anxiety in OSA.
Export Options
About this article
Cite this article as:
Surani Salim, Rao Shweta, Surani Saherish, Guntupalli Bharat and Subramanian Shyam, Anxiety and Depression in Obstructive Sleep Apnea: Prevalence and Gender/Ethnic Variance, Current Respiratory Medicine Reviews 2013; 9 (4) . https://dx.doi.org/10.2174/1573398X09666131217002138
DOI https://dx.doi.org/10.2174/1573398X09666131217002138 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Commentary: Research Highlights: IKKβ Mediates Aβ-Triggered Microglial Inflammation and Neuronal Death During Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Past, Present and Future of Nutrigenomics and its Influence on Drug Development
Current Drug Discovery Technologies Treatment of Cardiovascular Risk Factors in Women
Current Medicinal Chemistry Tuberculostatic Drugs Targeting Infections of the Central Nervous System
Anti-Infective Agents HIV-1 Tat Disrupts CX3CL1-CX3CR1 Axis in Microglia via the NF-κBYY1 Pathway
Current HIV Research Selective Elevation of Circulating CCL2/MCP1 Levels in Patients with Longstanding Post-vaccinal Macrophagic Myofasciitis and ASIA
Current Medicinal Chemistry Development of Nucleic Acid Drugs for Neurological Disorders
Current Topics in Medicinal Chemistry TREM2 and the Progression of Alzheimer’s Disease
Current Neurovascular Research Bilateral Interrelationship of Diabetes and Periodontium
Current Diabetes Reviews Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson’s Disease
Mini-Reviews in Medicinal Chemistry Clinical Importance of Assessment of Type 2 Diabetes Mellitus with Visceral Obesity. A Japanese Perspective
Current Diabetes Reviews Insulin-Like Growth Factor-1, a Potential Predicative Biomarker for Postoperative Delirium Among Elderly Patients with Open Abdominal Surgery
Current Pharmaceutical Design Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer’s Disease and Involvement of Neuroinflammation
Current Alzheimer Research Natural Products as Sources of New Lead Compounds for the Treatment of Alzheimer’s Disease
Current Topics in Medicinal Chemistry Repositioning of DHFR Inhibitors
Current Topics in Medicinal Chemistry Magnesium as a Neuroprotective Agent in Cerebral Ischemia
Current Medicinal Chemistry - Central Nervous System Agents Current Advances in Vehicles for Brain Gene Delivery
Current Gene Therapy Adrenomedullin Expression in Alzheimer's Brain
Current Alzheimer Research Amyotrophic Lateral Sclerosis: From Research to Therapeutic Attempts and Therapeutic Perspectives
Current Medicinal Chemistry Current Challenges to Overcome in the Management of Type 2 Diabetes Mellitus and Associated Neurological Disorders
CNS & Neurological Disorders - Drug Targets